Plant regeneration of Erigeron breviscapus (vant.) Hand. Mazz. and its chromatographic fingerprint analysis for quality control
- PMID: 17938931
- DOI: 10.1007/s00299-007-0466-9
Plant regeneration of Erigeron breviscapus (vant.) Hand. Mazz. and its chromatographic fingerprint analysis for quality control
Abstract
An efficient micropropagation system for Erigeron breviscapus (vant.) Hand. Mazz., an important medicinal plant for heart disease, has been developed. Shoot organogenesis occurred from E. breviscapus leaf explants inoculated on a medium supplemented with a combination of plant growth regulators. On average, 17 shoots per leaf explant were produced after 30 days when they were cultured on MS basal salts and vitamin medium containing 5 microM 6-benzylaminopurine (BAP) and 5 microM 1-naphthaleneacetic acid (NAA). All the regenerated shoots formed complete plantlets on a medium containing 2.5-10 microM indole-3-butyric acid (IBA) within 30 days, and 80.2% of the regenerated plantlets survived and grew vigorously in field conditions. Based on the variation in common peaks and the produced amount of the most important bioactive component, scutellarin, a high performance liquid chromatography (HPLC) fingerprinting system was developed for quality control of these micropropagated plants. Chemical constituents in E. breviscapus micropropagated plants varied during plant development from regeneration to maturation, the latter of which showed the most similar phytochemical profile in comparison with mother plants. The regeneration protocol and HPLC fingerprint analysis developed here provided a new approach to quality control of micropropagated plants producing secondary metabolites with significant implications for germplasm conservation.
Similar articles
-
In vitro propagation of an endangered medicinal plant Saussurea involucrata Kar. et Kir.Plant Cell Rep. 2007 Mar;26(3):261-5. doi: 10.1007/s00299-006-0230-6. Epub 2006 Sep 20. Plant Cell Rep. 2007. PMID: 16988830
-
Rapid in vitro plant regeneration from leaf explants of Launaea sarmentosa (Willd.) Sch. Bip. ex Kuntze.Biol Res. 2012;45(2):131-3. doi: 10.4067/S0716-97602012000200004. Biol Res. 2012. PMID: 23096356
-
Adventitious shoot regeneration from in vitro cultured leaves of London plane tree (Platanus acerifolia Willd.).Plant Cell Rep. 2003 Mar;21(7):640-4. doi: 10.1007/s00299-002-0569-2. Epub 2003 Feb 22. Plant Cell Rep. 2003. PMID: 12789413
-
Metabolism and Pharmacological Mechanisms of Active Ingredients in Erigeron breviscapus.Curr Drug Metab. 2021;22(1):24-39. doi: 10.2174/1389200221666201217093255. Curr Drug Metab. 2021. PMID: 33334284 Review.
-
Erigeron breviscapus (Vant.) Hand-Mazz.: A Promising Natural Neuroprotective Agent for Alzheimer's Disease.Front Pharmacol. 2022 Apr 26;13:877872. doi: 10.3389/fphar.2022.877872. eCollection 2022. Front Pharmacol. 2022. PMID: 35559239 Free PMC article. Review.
Cited by
-
Efficient regeneration and improved sonication-assisted Agrobacterium transformation (SAAT) method for Catharanthus roseus.3 Biotech. 2017 May;7(1):26. doi: 10.1007/s13205-016-0593-5. Epub 2017 Apr 11. 3 Biotech. 2017. PMID: 28401464 Free PMC article.
-
Rapid and Efficient Optimization Method for a Genetic Transformation System of Medicinal Plants Erigeron breviscapus.Int J Mol Sci. 2023 Mar 15;24(6):5611. doi: 10.3390/ijms24065611. Int J Mol Sci. 2023. PMID: 36982685 Free PMC article.
-
Protective Property of Scutellarin Against Liver Injury Induced by Carbon Tetrachloride in Mice.Front Pharmacol. 2021 Aug 5;12:710692. doi: 10.3389/fphar.2021.710692. eCollection 2021. Front Pharmacol. 2021. PMID: 34421606 Free PMC article.
-
Current advances on the therapeutic potential of scutellarin: an updated review.Nat Prod Bioprospect. 2024 Mar 4;14(1):20. doi: 10.1007/s13659-024-00441-3. Nat Prod Bioprospect. 2024. PMID: 38436812 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources